Storia in 2 fonti

Why Is GSK Stock Gaining Tuesday? - GSK (NYSE:GSK)

GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its 2026 guidance.

Raccontata da

fiercepharma.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo5 h fa

Why Is GSK Stock Gaining Tuesday? - GSK (NYSE:GSK)

GSK beat earnings targets and launched a £1.9B cost-reduction program by 2029 to manage dolutegravir patent expiry starting 2028. The savings enable margin defense and boost vaccines and specialty medicines, offsetting HIV blockbuster cliff impact on profitability and long-term growth outlook.

originale

fiercepharma.com9 h fa

GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

About half a year into his tenure as GSK’s CEO, Luke Miels is launch | About half a year into his tenure as GSK’s CEO, Luke Miels is launching a three-year restructuring designed to generate $2.5 billion in annual cost…

Timeline cronologica

martedì 28 luglio 2026·fiercepharma.com
GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain
About half a year into his tenure as GSK’s CEO, Luke Miels is launch | About half a year into his tenure as GSK’s CEO, Luke Miels is launching a three-year restructuring designed…
martedì 28 luglio 2026·benzinga.com
Why Is GSK Stock Gaining Tuesday? - GSK (NYSE:GSK)
GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its 2026 guidance.